Canada markets close in 5 hours 30 minutes

ARGX Jun 2024 320.000 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
3.00000.0000 (0.00%)
As of 11:23AM EDT. Market open.
Full screen
Previous Close3.0000
Open3.0000
Bid1.0000
Ask5.1000
Strike320.00
Expire Date2024-06-21
Day's Range3.0000 - 3.0000
Contract RangeN/A
Volume1
Open Interest129
  • GlobeNewswire

    argenx to unveil its ‘Vision 2030: Taking Breakthrough Science to 50,000 Patients’ during its Upcoming R&D Day on July 16, 2024

    R&D Day presentations to include recent Phase 2 datasets in Sjogren’s disease (efgartigimod) and multifocal motor neuropathy (empasiprubart) that support advancement to Phase 3 development Next wave of innovative pipeline candidates to be introduced highlighting long-term commitment to transform autoimmunity Decision to not advance development of efgartigimod in PC-POTS based on Phase 2 ALPHA data June 17, 2024, 7:00 AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a glob

  • GlobeNewswire

    argenx to Present at Goldman Sachs 45th Annual Global Healthcare Conference

    June 4, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of management will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024 at 2:40 PM ET in Miami, FL. A live webcast of the fireside chat may be accessed on the Investors section of the argenx website at argenx.com/inv

  • Investor's Business Daily

    After Biohaven Kerfuffle, Immunovant Dives On A Surprise Delay

    Immunovant stock slumped Thursday — reversing a day-earlier jump — after pivoting its focus to what one analyst called "a backup compound."